六味地黄丸对恶性黑色素瘤细胞Cx表达及GJIC的影响
|
摘要
恶性黑素瘤(malignant melanoma)是来源于黑色素细胞的恶性肿瘤,发病率为全身恶性肿瘤的1%—2%,其恶性程度高,预后差。随着分子生物学的发展,基因治疗给恶性肿瘤的治疗带来了曙光,恶性黑素瘤是最早进行基因治疗的恶性肿瘤之一。肿瘤的基因治疗,特别是肿瘤的自杀基因疗法,已经成为继传统的手术切除、放疗、化疗等方法后的一种新的抗肿瘤治疗措施。但单纯自杀基因治疗由于目前载体转染效率较低、靶向性不够等问题没解决,仍有部分肿瘤细胞残余导致肿瘤复发,这是该疗法存在的重大缺陷。因而增强旁杀伤效应目前已成为提高肿瘤自杀基因治疗疗效的重要策略。由于缝隙连接机制是旁杀伤效应的重要机制,故改善肿瘤的细胞间缝隙连接功能(GJIC)是自杀基因疗法增效的重要途径之一。以往的研究证明:六味地黄丸能够提高自杀基因的旁杀伤效应,而缝隙连接机制是旁杀伤效应的重要机制之一,故推测六味地黄丸可能具有提高GJIC功能的作用。
本研究应用中药复方血清药理学的方法,以小鼠恶性黑色素瘤B16细胞为研究对象,初步探讨六味地黄丸含药血清对小鼠恶性黑色素瘤增效作用的旁杀伤效应机制。通过研究以期为临床自杀基因疗法联合中药复方的中西医结合治疗方案的建立提供实验数据、科学依据及前期工作基础。
目的:本实验旨在以往研究的基础上,应用中药复方血清药理学方法,研究六味地黄丸含药血清对小鼠恶性黑色素瘤细胞(B16细胞)旁杀伤效应增效作用的缝隙连接机制。
方法:
1六味地黄丸药物血清和对照血清的制备:SD大鼠(230～280g),分为对照组和六味地黄丸给药组(药物剂量为等效剂量的6～8倍)。灌胃八天。末次给药后1小时腹主动脉取血,-70℃冰箱保存备用。
2六味地黄丸药物血清和对照血清添加量的确定:MTT法检测检测B16细胞对六味地黄丸含药血清和对照血清的敏感程度,确定用药浓度。
3六味地黄丸含药血清对恶性黑色素瘤GJIC功能的影响:用流式细胞技术检测和SLDT法观察六味地黄丸含药血清对B16细胞的GJIC功能的影响。
4六味地黄丸含药血清对恶性黑色素瘤细胞的缝隙连接蛋白Cx的影响:用western blot技术和间接免疫荧光技术检测六味地黄丸含药血清对恶性黑色素瘤细胞的缝隙连接蛋白Cx的影响。
结果:
1.血清的制备及含药血清的添加量
本实验给药方案采用每天灌胃2次,间隔8小时;灌胃后1h取血。从MTT结果来看,对照血清及六味地黄丸含药血清在5%～10%浓度下对小鼠恶性黑色素瘤细胞B16的生长有一定的促进作用,但是随着血清浓度增高(＞20%)会对细胞的形态产生明显的影响,镜下观察细胞形态发生空泡状改变。但数量上还是有所增值的,故选择对B16细胞影响不大的浓度(＜10%)作为大鼠血清的工作浓度。但六味地黄丸含药血清与对照血清对细胞影响无统计学差异(P＞0.05)。
2六味地黄丸含药血清对恶性黑色素瘤细胞GJIC功能的影响
SLDT法和流式细胞仪技术检测的结果都是:对照血清和含药血清都使得B16细胞GJIC功能得到增强,至于大鼠血清为什么使得GJIC功能增强,具体机制有待进一步研究,但是单看六味地黄丸含药血清组可以看出有一个量效关系,随着浓度的增加,其GJIC功能得到增强,说明六味地黄丸含药血清能够提高小鼠恶性黑色素瘤细胞的GJIC功能。
3六味地黄丸含药血清对恶性黑色素瘤细胞的缝隙连接蛋白的影响
Western blot技术和FITC检测结果显示:对照血清和六味地黄丸含药血清都使得Cx蛋白的表达提高,至于对照血清为什么能够提高Cx的表达,具体机制不明,有待进一步研究。单看六味地黄丸含药血清也能使Cx提高。且有明显的量效关系。说明六味地黄丸含药血清能够使小鼠恶性黑色素瘤细胞的Cx的表达有所提高。
结论:本研究在细胞水平探讨了六味地黄丸含药血清对小鼠恶性黑色素瘤细胞自杀基因疗法旁杀伤增效的作用机制。研究结果表明,六味地黄丸可能通过增强恶性黑色素瘤细胞Cx表达,从而增强缝隙连接功能,故旁杀伤效应的缝隙连接机制,可能是六味地黄丸对自杀基因疗法增效的机制之一。
Malignant melanoma is the malignant tumor which comes from melanin cell. Which is a type of melanin cell malignant tumor which originates neural crest .The outbreak rate is 1% to2% of the whole body malignant tumor. Its malignant degree is high, differing after preparing. With the development of molecular biology , the suicide gene therapy of the tumor has represented the good application prospect as a kind of new approach. But the problem in this remedy is insufficient killing ability, low efficiency of transfection and uncertain safety. It' s reported that increasing the bystander effect is a good approach to resolve this problem. Considering the most important mechanism of bystander effect conducted by the gap junction intercellular communication (GJIC) of cell, researchers today enhance the bystander effect by method of medical inducement to elevate GJIC. But there were not many medicines especially natural medicine with this effect had been found until today. Although some ingredients of TCM had been proved by the clinic or basic investigations on the effects of inducing apoptosis of tumor cells and increasing immunity of the patients, few articles were released about the investigation on increasing bystander effect and cooperating the tumor gene therapy with TCM or their ingredients. At the same time, research in the past proves that: Liu Wei Di Huang Bolus can be able to improve suicide gene bystander. The mechanism of gap junction is other one of bystander effect. Guess that Liu Wei Di Huang Bolus may be improving the GJIC function, which strengthen suicide gene bystander.
This research applies the method that the serum pharmacology of the Chinese herbal medicine compound prescribe learns, With malignant melanoma of mou-se cell for research object, We study the function mechanism research of enhancingutility of serum pharmacology of Liu wei Di huang Bolus on "bystander effect"of suicide gene therapy of malignant melanoma. We provid experimentdata, science basis and work foundation to treatment project of suicide genetherapy consociatio-n serum pharmacology of the Chinese herbal medicinecompound prescribe .
Objective:
During the research, we hoped to explore the possible mechanism of adjusting cell GJIC and inducing of cell apoptosis with Serum Phamacology of LiuweiDiduang Bolus, then we could get the further comprehension about the mechanism of increasing bystander effect with Serum Phamacology of LiuweiDiduang Bolus. Methods:
1. Preparation of the herbs serum of LiuweiDiduang Bolus and control serum:SD rat (230～280g), divided into two groups: one was control serum group, the other was Serum Phamacology of Liuwei Diduang Bolus (Administration: 6～8 times of isoeffect dosage). Getting blood from abdominal aorta after the Intragastric administration for one hour, Conservation of serum: -70°C frige.
2. The suitable Medication level of the herbs serum of LiuweiDiduang Bolus and control serum. Using MTT assay to detect the sensitivity of herbs serum of Liu Wei Di Huang Bolus and control serum on B16 cell. with the results to decide the suitable medication level.
3. The effects of the herbs serum of Liu Wei Di Huang Bolus on GJIC of malignant melanoma. the effects of herbs serum of Liu Wei Di Huang Bolus on the GJIC of B16 cell were detected by SLDT and FACS cell analyzer.
4. The effects of the herbs serum of Liu Wei Di Huang Bolus on C_X of B16. the effects of herbs serum of Liu Wei Di Huang Bolus on C_X of B16 were detected by western blot and FITC.
Results:
1. The preparation of rat serum and the addition of the herbs serum of Liuwei Diduang Bolus
The control serum and herbs serum of Liuwei Diduang Bolus showed a promotion effect on B16 cell when the final concentration was 5%～15% but showed inhibiting effect when higher than 20%(micro. Observation: the cells transformed into vacuoles). There was no statistical difference comparing the influences between the herbs serum of Liuwei Diduang Bolus and control serum on CBRH7919. (P>0. 05)
2. The effects of the herbs serum of Liu Wei Di Huang Bolus on GJIC of malignant melanoma
The result of SLDT and FACS cell analyzer showed that the ability of GJIC function of B16 was up-regulated by herbs serum of Liu Wei Di Huang Bolus and control serum. But why control serum can strengthen the ability of GJIC function of B16, the concrete mechanism pending further studies. Along with the density of herbs serum of Liu Wei Di Huang Bolus increase, its GJIC function obtains the enhancement, This indicated the ability of GJIC function of B16 was up-regulated by herbs serum of Liuwei Diduang Bolus.
3. The effects of the herbs serum of Liu Wei Di Huang Bolus on C_X protein of B16.
The result of western blot and FITC showed that C_X was up-regulated by herbs serum of Liu Wei Di Huang Bolus and control serum. But why control serum can strengthen C_X, the concrete mechanism pending further studies. Along with the density of herbs serum of Liuwei Diduang Bolus increase, The connexion expression has the enhancement, This indicated the expression of C_X was up-regulated by herbs serum of Liu Wei Di Huang Bolus.
Conclusion:
This research discussed The Mechanism Research of herbs serum of LiuWei Di Huang Bolus on GJIC of malig-nant melanoma .The analysis result indicated Liu Wei Di Huang Bolus strengthens the express of C_X of malignant melanoma, Which can strengthen the function of gap junction. The mechanism of gap junction of bystander effect may be one of the Liu Wei Di Huang Bolus mechanism to suicide gene treatment synergy.
本研究应用中药复方血清药理学的方法,以小鼠恶性黑色素瘤B16细胞为研究对象,初步探讨六味地黄丸含药血清对小鼠恶性黑色素瘤增效作用的旁杀伤效应机制。通过研究以期为临床自杀基因疗法联合中药复方的中西医结合治疗方案的建立提供实验数据、科学依据及前期工作基础。
目的:本实验旨在以往研究的基础上,应用中药复方血清药理学方法,研究六味地黄丸含药血清对小鼠恶性黑色素瘤细胞(B16细胞)旁杀伤效应增效作用的缝隙连接机制。
方法:
1六味地黄丸药物血清和对照血清的制备:SD大鼠(230～280g),分为对照组和六味地黄丸给药组(药物剂量为等效剂量的6～8倍)。灌胃八天。末次给药后1小时腹主动脉取血,-70℃冰箱保存备用。
2六味地黄丸药物血清和对照血清添加量的确定:MTT法检测检测B16细胞对六味地黄丸含药血清和对照血清的敏感程度,确定用药浓度。
3六味地黄丸含药血清对恶性黑色素瘤GJIC功能的影响:用流式细胞技术检测和SLDT法观察六味地黄丸含药血清对B16细胞的GJIC功能的影响。
4六味地黄丸含药血清对恶性黑色素瘤细胞的缝隙连接蛋白Cx的影响:用western blot技术和间接免疫荧光技术检测六味地黄丸含药血清对恶性黑色素瘤细胞的缝隙连接蛋白Cx的影响。
结果:
1.血清的制备及含药血清的添加量
本实验给药方案采用每天灌胃2次,间隔8小时;灌胃后1h取血。从MTT结果来看,对照血清及六味地黄丸含药血清在5%～10%浓度下对小鼠恶性黑色素瘤细胞B16的生长有一定的促进作用,但是随着血清浓度增高(＞20%)会对细胞的形态产生明显的影响,镜下观察细胞形态发生空泡状改变。但数量上还是有所增值的,故选择对B16细胞影响不大的浓度(＜10%)作为大鼠血清的工作浓度。但六味地黄丸含药血清与对照血清对细胞影响无统计学差异(P＞0.05)。
2六味地黄丸含药血清对恶性黑色素瘤细胞GJIC功能的影响
SLDT法和流式细胞仪技术检测的结果都是:对照血清和含药血清都使得B16细胞GJIC功能得到增强,至于大鼠血清为什么使得GJIC功能增强,具体机制有待进一步研究,但是单看六味地黄丸含药血清组可以看出有一个量效关系,随着浓度的增加,其GJIC功能得到增强,说明六味地黄丸含药血清能够提高小鼠恶性黑色素瘤细胞的GJIC功能。
3六味地黄丸含药血清对恶性黑色素瘤细胞的缝隙连接蛋白的影响
Western blot技术和FITC检测结果显示:对照血清和六味地黄丸含药血清都使得Cx蛋白的表达提高,至于对照血清为什么能够提高Cx的表达,具体机制不明,有待进一步研究。单看六味地黄丸含药血清也能使Cx提高。且有明显的量效关系。说明六味地黄丸含药血清能够使小鼠恶性黑色素瘤细胞的Cx的表达有所提高。
结论:本研究在细胞水平探讨了六味地黄丸含药血清对小鼠恶性黑色素瘤细胞自杀基因疗法旁杀伤增效的作用机制。研究结果表明,六味地黄丸可能通过增强恶性黑色素瘤细胞Cx表达,从而增强缝隙连接功能,故旁杀伤效应的缝隙连接机制,可能是六味地黄丸对自杀基因疗法增效的机制之一。
Malignant melanoma is the malignant tumor which comes from melanin cell. Which is a type of melanin cell malignant tumor which originates neural crest .The outbreak rate is 1% to2% of the whole body malignant tumor. Its malignant degree is high, differing after preparing. With the development of molecular biology , the suicide gene therapy of the tumor has represented the good application prospect as a kind of new approach. But the problem in this remedy is insufficient killing ability, low efficiency of transfection and uncertain safety. It' s reported that increasing the bystander effect is a good approach to resolve this problem. Considering the most important mechanism of bystander effect conducted by the gap junction intercellular communication (GJIC) of cell, researchers today enhance the bystander effect by method of medical inducement to elevate GJIC. But there were not many medicines especially natural medicine with this effect had been found until today. Although some ingredients of TCM had been proved by the clinic or basic investigations on the effects of inducing apoptosis of tumor cells and increasing immunity of the patients, few articles were released about the investigation on increasing bystander effect and cooperating the tumor gene therapy with TCM or their ingredients. At the same time, research in the past proves that: Liu Wei Di Huang Bolus can be able to improve suicide gene bystander. The mechanism of gap junction is other one of bystander effect. Guess that Liu Wei Di Huang Bolus may be improving the GJIC function, which strengthen suicide gene bystander.
This research applies the method that the serum pharmacology of the Chinese herbal medicine compound prescribe learns, With malignant melanoma of mou-se cell for research object, We study the function mechanism research of enhancingutility of serum pharmacology of Liu wei Di huang Bolus on "bystander effect"of suicide gene therapy of malignant melanoma. We provid experimentdata, science basis and work foundation to treatment project of suicide genetherapy consociatio-n serum pharmacology of the Chinese herbal medicinecompound prescribe .
Objective:
During the research, we hoped to explore the possible mechanism of adjusting cell GJIC and inducing of cell apoptosis with Serum Phamacology of LiuweiDiduang Bolus, then we could get the further comprehension about the mechanism of increasing bystander effect with Serum Phamacology of LiuweiDiduang Bolus. Methods:
1. Preparation of the herbs serum of LiuweiDiduang Bolus and control serum:SD rat (230～280g), divided into two groups: one was control serum group, the other was Serum Phamacology of Liuwei Diduang Bolus (Administration: 6～8 times of isoeffect dosage). Getting blood from abdominal aorta after the Intragastric administration for one hour, Conservation of serum: -70°C frige.
2. The suitable Medication level of the herbs serum of LiuweiDiduang Bolus and control serum. Using MTT assay to detect the sensitivity of herbs serum of Liu Wei Di Huang Bolus and control serum on B16 cell. with the results to decide the suitable medication level.
3. The effects of the herbs serum of Liu Wei Di Huang Bolus on GJIC of malignant melanoma. the effects of herbs serum of Liu Wei Di Huang Bolus on the GJIC of B16 cell were detected by SLDT and FACS cell analyzer.
4. The effects of the herbs serum of Liu Wei Di Huang Bolus on C_X of B16. the effects of herbs serum of Liu Wei Di Huang Bolus on C_X of B16 were detected by western blot and FITC.
Results:
1. The preparation of rat serum and the addition of the herbs serum of Liuwei Diduang Bolus
The control serum and herbs serum of Liuwei Diduang Bolus showed a promotion effect on B16 cell when the final concentration was 5%～15% but showed inhibiting effect when higher than 20%(micro. Observation: the cells transformed into vacuoles). There was no statistical difference comparing the influences between the herbs serum of Liuwei Diduang Bolus and control serum on CBRH7919. (P>0. 05)
2. The effects of the herbs serum of Liu Wei Di Huang Bolus on GJIC of malignant melanoma
The result of SLDT and FACS cell analyzer showed that the ability of GJIC function of B16 was up-regulated by herbs serum of Liu Wei Di Huang Bolus and control serum. But why control serum can strengthen the ability of GJIC function of B16, the concrete mechanism pending further studies. Along with the density of herbs serum of Liu Wei Di Huang Bolus increase, its GJIC function obtains the enhancement, This indicated the ability of GJIC function of B16 was up-regulated by herbs serum of Liuwei Diduang Bolus.
3. The effects of the herbs serum of Liu Wei Di Huang Bolus on C_X protein of B16.
The result of western blot and FITC showed that C_X was up-regulated by herbs serum of Liu Wei Di Huang Bolus and control serum. But why control serum can strengthen C_X, the concrete mechanism pending further studies. Along with the density of herbs serum of Liuwei Diduang Bolus increase, The connexion expression has the enhancement, This indicated the expression of C_X was up-regulated by herbs serum of Liu Wei Di Huang Bolus.
Conclusion:
This research discussed The Mechanism Research of herbs serum of LiuWei Di Huang Bolus on GJIC of malig-nant melanoma .The analysis result indicated Liu Wei Di Huang Bolus strengthens the express of C_X of malignant melanoma, Which can strengthen the function of gap junction. The mechanism of gap junction of bystander effect may be one of the Liu Wei Di Huang Bolus mechanism to suicide gene treatment synergy.
引文
1.邓洪新,田聆,魏于全.基因治疗的发展现状、问题和进展.生命科学,2005:17(3):196-199.
2.Check E.Gene-therapy trials to restart following cancer risk review.Nature,2005;434(7030):127-128.
3.杜标炎,谭宇蕙,吴映雅等.逆转录病毒载体介导HSV-tk/GCV肿瘤自杀基因治疗系统的构建[J].广州中医药大学学报,2004,21(5):395-398.
4.Tanaka M,Grossman HB.Connexin 26 gene therapy of human bladder cancer:induction of growth suppression,apoptosis,and synergy with Cisplatin.Hum Gene Ther.2001 Dec 10;12(18):2225-36.Erratum in:Hum Gene Ther 2002Jan 20;13(2):344-345.[PMID:11779406]
5.Im SA,Gomez-Manzano C,Fueyo J,et al.Antiangiogenesis treatment for gliomas:transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.Cancer Res,1999;59(4):895-898.
6.Zatloukal K,Schmidt W,Cotten M.Somatic gene therapy for cancer:the utility of transferrinfection in generating 'tumor vaccines'.Gene,1993;135(1-2):199-201.
7.Kobayashi H,Takemura Y,Miyachi H.Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.Hum Cell,2001:14(3):172-175.
8.Sorrentino BP,McDonagh KT,Woods D,et al.Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice.Blood,1995;86(2):491-496.
9.蔡洪培,邓志华,李石等.反义核酸抗肿瘤治疗研究中靶基因的选择.中国肿瘤生物治疗杂志,1998;5(2):148-151.
10.陈建发,黄宗海.前药转换酶/前药体系的研究进展.肿瘤防治杂志.2004:11(4):417-421.
11.Moohen F al.Hum Gene Ther,Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene 1990:1(2):125-134.
12.Mesnil M,Yamasaki H.Bystander effect in herpes simplex virus-thymidine kinase/ganciclvir cancer gene therapy:role of gap-junctional intercellular communication.Cancer Res,2000;60(15):3989-3992.
13.孙春晓,何荣根.恶性肿瘤自杀基因治疗研究进展.实用肿瘤杂志,1999;14(4):255-259.
14.Greco O,Dachs GU.Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives [J].JCell Physiol ,2001 ,187(1) : 22 - 36.
15. Culver KW. Ram Z, Wallbridge S, etal. In vivo gene transfer with retroviral vector-producer cells for treatment brain tumors.Sceence.1992;256(5063):1550-1556.
16. Frank Mc, Cormick. Cancer gene therapy fringe or cutting edge? Nature Review (cancer), 2002, Nor(1): 1-12.
17. 梁智勇,史景泉. 缝隙连接细胞间通讯与肿瘤的关系. 临床与实验病理学杂志 2001;17(5): 432-434.
18. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):183-185. PMID: 8700844
19. Tanaka T, Yamasaki H, Mesnil M. Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes.Mol Carcinog. 2001 Mar;30(3):176-180. PMID: 11301478
20. Touraine RL, Vahanian N, Ramsey WJ, Blaese RM. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.Hum Gene Ther. 1998 Nov 1;9(16):238-291. PMID: 9829537
21.Ramesh R, Marrogi AJ, Munshi A, et al.In vivo analysis of the 'bystander effect': a cytokine cascade. Exp Hematol, 1996; 24(7): 829-832.
22. Pizzato M, Franchin E, Calvi P, et al. Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. Gene Ther, 1998; 5(7): 1003-1006.
23. Dilber MS, Abedi MR, Bjorkstrand B, et al. Suicide gene therapy for plasma cell tumors. Blood, 1996; 88(6): 2192-2196.
24. Hirschowitz EA, Ohwada A, Pascal WR, et al. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum Gene Ther, 1995; 6(8): 1055-1058.
25. Denning C, Pitts JD. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes.Hum 6ene Ther,1997;8(15):1825-1829.
26.Bouvet M,Ellis LM,Nishizaki M,et al.idenovirus-mediated wild-type p53gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.Cancer Res,1998;58(11):2288-2292.
27.Xu D,Falke D,Juliano Rh.p53-dependent cell-killing by selective repression of thymidine kinase and reduced prodrug activation.Mol Pharmacol.2003;64(2):289-294.
28.Paul D.Boucher,Donna S.Shewach.In Vitro and in Vivo Enhancement of Ganciclovir-Mediated Bystander Cytotoxicity with Gemcitabine.MOLECULAR THERAPY 2005;12(6):1064-1071.
29.ang AX,Huang HZ.All-trans retinoic acid augments the bystander effect of herpes simplex virus thymidine kinase/ganciclovir system in the treatment of tongue carcinoma cell line.Zhonghua Kou Qiang Yi Xue Za Zhi.2003 Jan;38(1):24-26.
30.张阿丽,卢运萍,王世宣等.卵巢癌自杀基因治疗的旁观者效应及其于间隙连接蛋白43表达的关系.中华妇产科杂志,2001,36(9):542-545.
31.孙华,刘耕陶.细胞间隙连接通讯与肿瘤.中国药理学通报.2004Nov:20(11):1205-1208.
32.刑毅飞,肖亚军,鲁功成.连接蛋白介导的GJIC与肿瘤自杀基因治疗时旁观者效应的关系.国外医学.生理、理科学与临床分册.2001:21(4):246-248.
33.王卫东综述,陈正堂,王志新审阅 缝隙连接与自杀基因旁观者效应研究进展.中国肿瘤生物治疗杂志.2001;8(3):231-233.
34.袁慧,浦跃朴.细胞间隙连接通讯与癌变关系的研究进展.中国预防医学杂志2004:15(11):67-68.
35.JUAN C.S AEZ,VIVIANA M.BERTHOUD,MARIA C.BRA NES,et al.Plasma Membrane Channels Formed by Connexins.:Their Regulation and Functions.Physiol Rev.2003;83:1360-1400.
36.Sullivan R,Ruangvoravat C,Joo D,Morgan J,Wang BL,Wang XK,and Lo CW.Structure,sequence and expression of the mouse Cx43 gene encoding connexin 43.Gene.1993;130:191-199.
37.Hennemann H,Kozjek G,Dahl E,Nicholson B,and Willecke K.Molecular cloning of mouse connexins26 and-32:similar genomic organization but distinct promoter sequences of two gap junction genes.1992;Eur J Cell Biol 58:81-89.
38.Kiang DT,Jin N,Tu ZJ,and Lin HH.Upstream genomic sequence of the human connexin26 gene.Gene.1997;199:165-171.
39.Gabriel HD,Strobol B,Hellmann P,Buettner R,and Winterhager E.Organization and regulation of the rat Cx31 gene.Implication for a crucial role of the intron region.Eur J Biochem.2001;268:1749-1759.
40.rrosko JE,Chang CC.Mechanism of up-regulated gap junction:an intercellular communication during chemoprevention and chemotherapy of cancer[J].MutatRes,2001,480(1):219-229.
41.Kang KS,Yun JW,Yoon B et al.Preventive effect of germanumdioxideon the inhibition of gap junctional intercellular communication by TPA[J].CancerLett,2001,166(2):147-153.
42.Edgar R,Hanne O.Role of PKC and MAPK kinase in EGF and TPA-induced connexin43 phosphorylation and inhibition of gap junction intercellular communication inratliver epithelial cells[J].Carcinogenesis,2001,22(9):1543-1550.
43.Butkevich E,Hulsmann S,Wenzel D,Shirao T,Duden R,Majoul I.Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton.Curr Biol.2004 Apt 20;14(8):650-658.
44.Kwak BR,van Veen TA,Analbers LJ,et al.TPA increases conductance by decreases permeability in neonatal rat cardiomyocyte gap junction channels[J].Exp Cell Res,1995,220(2):456-463.
45.姚庆华,郭勇.细胞间隙连接通讯、连接蛋白与肿瘤的抑制.肿瘤研究与临床.2005:17(1):67-70.
46.Omori Y,Zaidan Dagli ML,Yamakage K,et al.Involvement of gap junctions in tumor suppression:analysis of genetically2manipulated mice[J].Mutat Res,2001,477(122):191-196.
47.毛丽敏,王勤,王菊芳.肿瘤细胞的间隙连接.国外医学肿瘤学分册.2003:30(4):266-269.
48.King TJ,Lampe PD.Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kipl-deficient mice.Cell Commun Adhes.2005Jul-Dec;12(5-6):293-305.
49.Ale Agha N,Stahl W,Sies H.(-)2Epicatechin effects in rat liver epithelial cells:stimulation of gap junctional communication ang counteraction of its loss due to the tumor promoter 12-O-tetradecanoylphorbol2132acetate[J ] . Biochem Pharmacol . 2002 , 63 (12) : 2145-2149.
50. Edward Leithe, Edgar Rivedal. Ubiquitination and Down-regulation of Gap Junction Protein Connexin-43 in Response to 12-O-Tetradecanoylphorbol 13-Acetate Treatment. THE JOURNAL OF BIOLOGICAL CHEMISTRY. 2004;279(48): 50089- 50096.
51. Roberts PC, Mottillo EP, Baxa AC, Heng HH, Doyon-Reale N, Gregoire L, Lancaster WD, Rabah R, Schmelz EM. Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model. Neoplasia. 2005 Oct;7(10):944-956.
52. King TJ, Lampe PD. Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kipl-deficient mice. Cell Commun Adhes. 2005 Jul-Dec;12(5-6):293-305.
53. Sheen IS, Jeng KS, Wang PC, Shih SC, Chang WH, Wang HY, Chen CC, Shyung LR. Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study. World J Gastroenterol. 2004 Oct 1;10(19):2785-2790.
54. Mesnil M. Gap junctions and cancer: implications and perspectives. Med Sci (Paris). 2004 Feb;20(2):197-206.
55. Omori Y, Kmtovskikh V, TmdaH, et al. Cx32 gene mutation in a chemi· cally—induced ratliverminor. Carcinogenesis. 1996c 17: 1077—1080.
56. Plante I, Charbonneau M, Cyr DG. Decreased gap junctional intercel · lular communication in hexachlombemene — induced gender —specifichepatic tumor formation in the rat. Carcinogenesis, 2002, 23: 1243-1249.
57. Asamoto M, Takahashi S, Imaida K, et al. Increased gap junetional intercellular communication capacity and connexin 43 and 26 expressionin rat bladder. Carcinogenesis, 1994, 15: 2163-2166.
58. Wilgenbus KK, Kirkpatrick CJ, Knueche LR, et al. Expression Of Cx26, Cx32, Cx43 gapjunction proteins in normal and neoplastic human tissues. Int J Cancer, 1992, 51: 522-529.
59. Rnch RJ, Trosko JE, Madhukar BV. Inhibition Of connex ion 43 gap junetional intercellular conmamieation by TPA requires ERK activation . J Cell Biochem. 2001. 83: 163-169.
60.Nnguchi M,Nomata K,Watanabe JI.et al.Disruption Of gap junetional Intercellular communication in human renal cancer cell lines.Urology,1999.53:218-222.
61.Li G,Satyamoorthy K,Herlyn M.Dynamics Of cell interactions and communications during melanoma development.Crit BevOral Bid Med,2002.13:62-70.
62.Yamssaki H,Omori Y,Zaidan—Dagli ML,et al.Genetic and epige-netic changes Of interceluar communication genes during multistagecinogenesis.Cancer Detect Prev,1999,23:273-279.
63.Trosko JE.The role Of stem cells and gap junctional intercellular communication in.carcinogenesis.J Biochem Mol Bid.2003.36:43-48.
64.邱国橙.陈君柱.连接蛋白及细胞间连接通讯的调控国外医学分子生物学分册,1999;21(3):144-148.
65.Sulkowski S,SutkowskaM,Skrzydlewska E.Gap Junctional intercellular communication and carninogenesis Pol J Pathol,1999;(4):227-330
66.林仲翔,张志谦,王耐勤.间隙连接基因Cx43表达对肺癌细胞体内成瘤生长的抑制.中华肿瘤杂志,1997,19(4):253-255.
67.King TJ,Bertram JS.Connexins as targets for cancer chemoprevention and chemotherapy.Biochim Biophys acta.2005:1719(1-2):146-160.[PMID:16263076]
68.夏之柏,浦佩玉,王广秀.转染连接蛋白基因对胶质瘤细胞细胞间隙连接通讯及其生长变化的研究.中华实验外科杂志2003:7:161-167.
69.EL-Fouly MH,Trosko J E,Chang CC.Scrape2loading and dye transfer:Arapid and simple technique to study gap junctional intercellular communication.Exp Cell Res,1987:168-422.
70.Margaret H,James E.A fluoresecence phorobleaching assay of gap junction medicated communication between human cells.Science,1983;232-525
71.李楠,徐勤生,杨军等.激光扫描共聚焦显微镜监测细胞间隙连接通讯的方法.中国体视学与图像分析,1997;2(2):57-59
72.Dennis LK.Analysis of the melanoma epidemic,both apparent and real:data from the 1973 through 1994 surveillance,epidemiology,and end results program registry[J].Arch Dermatol,1999;135(3):275-280.
73.Klatzmann D,Ch6rin P,Bensimon G,et al.A phase-Ⅰ/Ⅱdose-escalation study of herpes simplex virus ype 1 thymidinekinase "suicide" gene therapy for metastatic melanoma[J].Human Gene Therap,1998:9(17):2585-2594.
74.Schneeberger A,Goos M,Stingl G,et al.Management ofmalignant melanom a:new developments in immune and genetherapy[J].Clin Exp Dermatol,2000;25(6):509-519.
75.Putney SD,Brown J,Cucco C,et al.Enhanced anti-tumor effects with microencapsulated c-myc antisenseoligonucleot de[J].Antisense Nucleic Acid Drug Dev,1999;9(5):451-458.
76.Soiffer R,Lynch T,Mibm M,et al.Vaccination withirradiated autologous melanoma cells engineered to secrete human granulocyte -macrophage colony-stimulating factorgenerates potent antitumor im munity in patients with metastatic melanoma[J].Proc Natl Acad Sci U S A,1998;95(22):13141-13146.
77.roshiaki K,Malcolm A,Moore S,et al.Crystal Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors E J].Blood,2000;96(1):91-99.
78.Marchand GS,Noiseux N,Tanguay J F,et al.Blockade of invivo VEGF-mediated angiogenesis by antisense gene therapy:role of Flk-1 and Fh-1receptors[J].Am J Physiol Heart CircPhysiol,2002;282(1):194-204.
79.郁仁存,姜廷良,于尔辛主编.肿瘤研究.上海科学技术出版社,1991:17(3):100-110.
80.齐春会,张永祥,李凤仙等.六味地黄多糖体外抗肿瘤作用的初步研究.中国药理学通报,1999;15(4):322.
81.许继平,周振鹤,杨锋等.六味地黄口服液抗肿瘤化疗药物毒副作用 究.中国中西医结合杂志,1992;12(12):734-737.
82.贾振和等.六味地黄丸预防食道癌放疗中外周血象降低54例.中医杂志,2001:42(7):402-405.
83.姜延良.六味地黄汤防治肿瘤的实验研究,中医杂志,1983;24(6):71.
84.杨胜,张永祥,吕晓东等.六味地黄汤活性部位3A的免疫调节作用机理研究.中国中西结合杂志,2001:21(2):119-123.
85.姜廷良,严述常,王素芬等.六味地黄丸防治肿瘤的实验研究[J].中药方剂研究,1983;10(6):71-75.
86.Carystinos GD,Katabi MM,Laird DW,et al.Cyclic-AMP induction of gap junctional intercellular communication increases by stander effect in suicide gene therapy[J].Clin Caner Res,1999;5(5):61-68.
87.雷燕.关于中药血清学的若干思考[J]中国中西医结合志,1999,19(5):263.
88.崔晓兰,贺玉琢.高英杰中药药理研究的新思路一中药血清药理学[J].中国中医药科技1997.4(4):239-250.
89.荣一纯,丁霞,贲长恩等中药血清药理学应用展望[J]。北京中医药大学学报.1999.22(4):42-44.
90.绦瑶,卞国武,矍敏毓等.淫羊藿酵提物对内皮细胞释放NO的影响[J]中国新药与临床葑理2001 12(1):38-40.
91.赵万红,曹永孝,袁泽飞.中药血清药理学的方法探讨(J).中药新药与临床药理,2002:13(2):122-125.
92.蒙一纯,丁霞,郭顺根.中药血清药理学应用研究展望(J)北京中医药大学学报,1999:22(4):42-45.
93.阴桢宏,谭余庆,霍海如等.中药血清药理学研究方法及其应用.中国实验方剂学杂志.1997:3(6):41-45.
94.殷飞,姚树坤,吴新满等.肝症口服液含药血清对TGFA诱导SMMC-7721细胞增殖和ERK蛋白的影响[J].世界华人消化杂志,2001:9(9):1017-1020.
95.周明眉,扬奎,姜远平等.中药血清药理学的方法学研究一含药血清低温保存和血清灭活的影响.中药药理与临床。1999:15(2):44-47.
96.程珠炉,洪浩.中药血清药理学研究方法的几点思考.安徽中医学院学报2001:20(2):53-54.
97.崔玲,晏卫东.中药血清药理研究方法回顾与展望.武警学.2004:15(6):460-461.
98.司徒镇强,吴军正.细胞培养,西安:世界图书出版公司,2003:81-186.
99.刘振英,蔡迎.儿童胫骨棘撕脱性骨折[J].中华骨科杂志,1995,15(7):422-424.
100.陈长勋,金若敏等.用血清药理学实验方法观察附子的强心作用.中国中医药科技,1996;3(3):12-15.
101.吴建宇,李仪奎,符胜光等.补阳还五烫保护自由基损伤内皮细胞的血清药理实验方法的建立[J].中药药理与临床,1999,15(1):45-46
102.Lee SW,Tomasetto C,Sager R.Positive selection of candidate tumor suppressor gene by substractive hybridization.Proc Natl Acad Sci U S A,1991,88(7):2825-2829.
103.Kiang DT,Jin N,Lin HH.Gene expression of gap junction proteins in benign and malignant human breast tissues.Proc Am Assoc Cancer Res,1994,35:276-280.
104.Hirschi KK,Xu C,Tsukamoto T,et al.Gap junction gene Cx26 and Cx43individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential.Cell Growth Diff,1996,7(7):861-870.
105.程蕾,李静,耿美玉.细胞间隙连接通讯与肿瘤.现代生物医学展.2007:7(4):626-627.
106.郑良朴,高冬,林久茂.灌胃刺激对小鼠骨髓造血干细胞的影响.中国比较医学杂志.2008:18(2):52-54.
2.Check E.Gene-therapy trials to restart following cancer risk review.Nature,2005;434(7030):127-128.
3.杜标炎,谭宇蕙,吴映雅等.逆转录病毒载体介导HSV-tk/GCV肿瘤自杀基因治疗系统的构建[J].广州中医药大学学报,2004,21(5):395-398.
4.Tanaka M,Grossman HB.Connexin 26 gene therapy of human bladder cancer:induction of growth suppression,apoptosis,and synergy with Cisplatin.Hum Gene Ther.2001 Dec 10;12(18):2225-36.Erratum in:Hum Gene Ther 2002Jan 20;13(2):344-345.[PMID:11779406]
5.Im SA,Gomez-Manzano C,Fueyo J,et al.Antiangiogenesis treatment for gliomas:transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.Cancer Res,1999;59(4):895-898.
6.Zatloukal K,Schmidt W,Cotten M.Somatic gene therapy for cancer:the utility of transferrinfection in generating 'tumor vaccines'.Gene,1993;135(1-2):199-201.
7.Kobayashi H,Takemura Y,Miyachi H.Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.Hum Cell,2001:14(3):172-175.
8.Sorrentino BP,McDonagh KT,Woods D,et al.Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice.Blood,1995;86(2):491-496.
9.蔡洪培,邓志华,李石等.反义核酸抗肿瘤治疗研究中靶基因的选择.中国肿瘤生物治疗杂志,1998;5(2):148-151.
10.陈建发,黄宗海.前药转换酶/前药体系的研究进展.肿瘤防治杂志.2004:11(4):417-421.
11.Moohen F al.Hum Gene Ther,Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene 1990:1(2):125-134.
12.Mesnil M,Yamasaki H.Bystander effect in herpes simplex virus-thymidine kinase/ganciclvir cancer gene therapy:role of gap-junctional intercellular communication.Cancer Res,2000;60(15):3989-3992.
13.孙春晓,何荣根.恶性肿瘤自杀基因治疗研究进展.实用肿瘤杂志,1999;14(4):255-259.
14.Greco O,Dachs GU.Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives [J].JCell Physiol ,2001 ,187(1) : 22 - 36.
15. Culver KW. Ram Z, Wallbridge S, etal. In vivo gene transfer with retroviral vector-producer cells for treatment brain tumors.Sceence.1992;256(5063):1550-1556.
16. Frank Mc, Cormick. Cancer gene therapy fringe or cutting edge? Nature Review (cancer), 2002, Nor(1): 1-12.
17. 梁智勇,史景泉. 缝隙连接细胞间通讯与肿瘤的关系. 临床与实验病理学杂志 2001;17(5): 432-434.
18. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):183-185. PMID: 8700844
19. Tanaka T, Yamasaki H, Mesnil M. Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes.Mol Carcinog. 2001 Mar;30(3):176-180. PMID: 11301478
20. Touraine RL, Vahanian N, Ramsey WJ, Blaese RM. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.Hum Gene Ther. 1998 Nov 1;9(16):238-291. PMID: 9829537
21.Ramesh R, Marrogi AJ, Munshi A, et al.In vivo analysis of the 'bystander effect': a cytokine cascade. Exp Hematol, 1996; 24(7): 829-832.
22. Pizzato M, Franchin E, Calvi P, et al. Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. Gene Ther, 1998; 5(7): 1003-1006.
23. Dilber MS, Abedi MR, Bjorkstrand B, et al. Suicide gene therapy for plasma cell tumors. Blood, 1996; 88(6): 2192-2196.
24. Hirschowitz EA, Ohwada A, Pascal WR, et al. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum Gene Ther, 1995; 6(8): 1055-1058.
25. Denning C, Pitts JD. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes.Hum 6ene Ther,1997;8(15):1825-1829.
26.Bouvet M,Ellis LM,Nishizaki M,et al.idenovirus-mediated wild-type p53gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.Cancer Res,1998;58(11):2288-2292.
27.Xu D,Falke D,Juliano Rh.p53-dependent cell-killing by selective repression of thymidine kinase and reduced prodrug activation.Mol Pharmacol.2003;64(2):289-294.
28.Paul D.Boucher,Donna S.Shewach.In Vitro and in Vivo Enhancement of Ganciclovir-Mediated Bystander Cytotoxicity with Gemcitabine.MOLECULAR THERAPY 2005;12(6):1064-1071.
29.ang AX,Huang HZ.All-trans retinoic acid augments the bystander effect of herpes simplex virus thymidine kinase/ganciclovir system in the treatment of tongue carcinoma cell line.Zhonghua Kou Qiang Yi Xue Za Zhi.2003 Jan;38(1):24-26.
30.张阿丽,卢运萍,王世宣等.卵巢癌自杀基因治疗的旁观者效应及其于间隙连接蛋白43表达的关系.中华妇产科杂志,2001,36(9):542-545.
31.孙华,刘耕陶.细胞间隙连接通讯与肿瘤.中国药理学通报.2004Nov:20(11):1205-1208.
32.刑毅飞,肖亚军,鲁功成.连接蛋白介导的GJIC与肿瘤自杀基因治疗时旁观者效应的关系.国外医学.生理、理科学与临床分册.2001:21(4):246-248.
33.王卫东综述,陈正堂,王志新审阅 缝隙连接与自杀基因旁观者效应研究进展.中国肿瘤生物治疗杂志.2001;8(3):231-233.
34.袁慧,浦跃朴.细胞间隙连接通讯与癌变关系的研究进展.中国预防医学杂志2004:15(11):67-68.
35.JUAN C.S AEZ,VIVIANA M.BERTHOUD,MARIA C.BRA NES,et al.Plasma Membrane Channels Formed by Connexins.:Their Regulation and Functions.Physiol Rev.2003;83:1360-1400.
36.Sullivan R,Ruangvoravat C,Joo D,Morgan J,Wang BL,Wang XK,and Lo CW.Structure,sequence and expression of the mouse Cx43 gene encoding connexin 43.Gene.1993;130:191-199.
37.Hennemann H,Kozjek G,Dahl E,Nicholson B,and Willecke K.Molecular cloning of mouse connexins26 and-32:similar genomic organization but distinct promoter sequences of two gap junction genes.1992;Eur J Cell Biol 58:81-89.
38.Kiang DT,Jin N,Tu ZJ,and Lin HH.Upstream genomic sequence of the human connexin26 gene.Gene.1997;199:165-171.
39.Gabriel HD,Strobol B,Hellmann P,Buettner R,and Winterhager E.Organization and regulation of the rat Cx31 gene.Implication for a crucial role of the intron region.Eur J Biochem.2001;268:1749-1759.
40.rrosko JE,Chang CC.Mechanism of up-regulated gap junction:an intercellular communication during chemoprevention and chemotherapy of cancer[J].MutatRes,2001,480(1):219-229.
41.Kang KS,Yun JW,Yoon B et al.Preventive effect of germanumdioxideon the inhibition of gap junctional intercellular communication by TPA[J].CancerLett,2001,166(2):147-153.
42.Edgar R,Hanne O.Role of PKC and MAPK kinase in EGF and TPA-induced connexin43 phosphorylation and inhibition of gap junction intercellular communication inratliver epithelial cells[J].Carcinogenesis,2001,22(9):1543-1550.
43.Butkevich E,Hulsmann S,Wenzel D,Shirao T,Duden R,Majoul I.Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton.Curr Biol.2004 Apt 20;14(8):650-658.
44.Kwak BR,van Veen TA,Analbers LJ,et al.TPA increases conductance by decreases permeability in neonatal rat cardiomyocyte gap junction channels[J].Exp Cell Res,1995,220(2):456-463.
45.姚庆华,郭勇.细胞间隙连接通讯、连接蛋白与肿瘤的抑制.肿瘤研究与临床.2005:17(1):67-70.
46.Omori Y,Zaidan Dagli ML,Yamakage K,et al.Involvement of gap junctions in tumor suppression:analysis of genetically2manipulated mice[J].Mutat Res,2001,477(122):191-196.
47.毛丽敏,王勤,王菊芳.肿瘤细胞的间隙连接.国外医学肿瘤学分册.2003:30(4):266-269.
48.King TJ,Lampe PD.Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kipl-deficient mice.Cell Commun Adhes.2005Jul-Dec;12(5-6):293-305.
49.Ale Agha N,Stahl W,Sies H.(-)2Epicatechin effects in rat liver epithelial cells:stimulation of gap junctional communication ang counteraction of its loss due to the tumor promoter 12-O-tetradecanoylphorbol2132acetate[J ] . Biochem Pharmacol . 2002 , 63 (12) : 2145-2149.
50. Edward Leithe, Edgar Rivedal. Ubiquitination and Down-regulation of Gap Junction Protein Connexin-43 in Response to 12-O-Tetradecanoylphorbol 13-Acetate Treatment. THE JOURNAL OF BIOLOGICAL CHEMISTRY. 2004;279(48): 50089- 50096.
51. Roberts PC, Mottillo EP, Baxa AC, Heng HH, Doyon-Reale N, Gregoire L, Lancaster WD, Rabah R, Schmelz EM. Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model. Neoplasia. 2005 Oct;7(10):944-956.
52. King TJ, Lampe PD. Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kipl-deficient mice. Cell Commun Adhes. 2005 Jul-Dec;12(5-6):293-305.
53. Sheen IS, Jeng KS, Wang PC, Shih SC, Chang WH, Wang HY, Chen CC, Shyung LR. Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study. World J Gastroenterol. 2004 Oct 1;10(19):2785-2790.
54. Mesnil M. Gap junctions and cancer: implications and perspectives. Med Sci (Paris). 2004 Feb;20(2):197-206.
55. Omori Y, Kmtovskikh V, TmdaH, et al. Cx32 gene mutation in a chemi· cally—induced ratliverminor. Carcinogenesis. 1996c 17: 1077—1080.
56. Plante I, Charbonneau M, Cyr DG. Decreased gap junctional intercel · lular communication in hexachlombemene — induced gender —specifichepatic tumor formation in the rat. Carcinogenesis, 2002, 23: 1243-1249.
57. Asamoto M, Takahashi S, Imaida K, et al. Increased gap junetional intercellular communication capacity and connexin 43 and 26 expressionin rat bladder. Carcinogenesis, 1994, 15: 2163-2166.
58. Wilgenbus KK, Kirkpatrick CJ, Knueche LR, et al. Expression Of Cx26, Cx32, Cx43 gapjunction proteins in normal and neoplastic human tissues. Int J Cancer, 1992, 51: 522-529.
59. Rnch RJ, Trosko JE, Madhukar BV. Inhibition Of connex ion 43 gap junetional intercellular conmamieation by TPA requires ERK activation . J Cell Biochem. 2001. 83: 163-169.
60.Nnguchi M,Nomata K,Watanabe JI.et al.Disruption Of gap junetional Intercellular communication in human renal cancer cell lines.Urology,1999.53:218-222.
61.Li G,Satyamoorthy K,Herlyn M.Dynamics Of cell interactions and communications during melanoma development.Crit BevOral Bid Med,2002.13:62-70.
62.Yamssaki H,Omori Y,Zaidan—Dagli ML,et al.Genetic and epige-netic changes Of interceluar communication genes during multistagecinogenesis.Cancer Detect Prev,1999,23:273-279.
63.Trosko JE.The role Of stem cells and gap junctional intercellular communication in.carcinogenesis.J Biochem Mol Bid.2003.36:43-48.
64.邱国橙.陈君柱.连接蛋白及细胞间连接通讯的调控国外医学分子生物学分册,1999;21(3):144-148.
65.Sulkowski S,SutkowskaM,Skrzydlewska E.Gap Junctional intercellular communication and carninogenesis Pol J Pathol,1999;(4):227-330
66.林仲翔,张志谦,王耐勤.间隙连接基因Cx43表达对肺癌细胞体内成瘤生长的抑制.中华肿瘤杂志,1997,19(4):253-255.
67.King TJ,Bertram JS.Connexins as targets for cancer chemoprevention and chemotherapy.Biochim Biophys acta.2005:1719(1-2):146-160.[PMID:16263076]
68.夏之柏,浦佩玉,王广秀.转染连接蛋白基因对胶质瘤细胞细胞间隙连接通讯及其生长变化的研究.中华实验外科杂志2003:7:161-167.
69.EL-Fouly MH,Trosko J E,Chang CC.Scrape2loading and dye transfer:Arapid and simple technique to study gap junctional intercellular communication.Exp Cell Res,1987:168-422.
70.Margaret H,James E.A fluoresecence phorobleaching assay of gap junction medicated communication between human cells.Science,1983;232-525
71.李楠,徐勤生,杨军等.激光扫描共聚焦显微镜监测细胞间隙连接通讯的方法.中国体视学与图像分析,1997;2(2):57-59
72.Dennis LK.Analysis of the melanoma epidemic,both apparent and real:data from the 1973 through 1994 surveillance,epidemiology,and end results program registry[J].Arch Dermatol,1999;135(3):275-280.
73.Klatzmann D,Ch6rin P,Bensimon G,et al.A phase-Ⅰ/Ⅱdose-escalation study of herpes simplex virus ype 1 thymidinekinase "suicide" gene therapy for metastatic melanoma[J].Human Gene Therap,1998:9(17):2585-2594.
74.Schneeberger A,Goos M,Stingl G,et al.Management ofmalignant melanom a:new developments in immune and genetherapy[J].Clin Exp Dermatol,2000;25(6):509-519.
75.Putney SD,Brown J,Cucco C,et al.Enhanced anti-tumor effects with microencapsulated c-myc antisenseoligonucleot de[J].Antisense Nucleic Acid Drug Dev,1999;9(5):451-458.
76.Soiffer R,Lynch T,Mibm M,et al.Vaccination withirradiated autologous melanoma cells engineered to secrete human granulocyte -macrophage colony-stimulating factorgenerates potent antitumor im munity in patients with metastatic melanoma[J].Proc Natl Acad Sci U S A,1998;95(22):13141-13146.
77.roshiaki K,Malcolm A,Moore S,et al.Crystal Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors E J].Blood,2000;96(1):91-99.
78.Marchand GS,Noiseux N,Tanguay J F,et al.Blockade of invivo VEGF-mediated angiogenesis by antisense gene therapy:role of Flk-1 and Fh-1receptors[J].Am J Physiol Heart CircPhysiol,2002;282(1):194-204.
79.郁仁存,姜廷良,于尔辛主编.肿瘤研究.上海科学技术出版社,1991:17(3):100-110.
80.齐春会,张永祥,李凤仙等.六味地黄多糖体外抗肿瘤作用的初步研究.中国药理学通报,1999;15(4):322.
81.许继平,周振鹤,杨锋等.六味地黄口服液抗肿瘤化疗药物毒副作用 究.中国中西医结合杂志,1992;12(12):734-737.
82.贾振和等.六味地黄丸预防食道癌放疗中外周血象降低54例.中医杂志,2001:42(7):402-405.
83.姜延良.六味地黄汤防治肿瘤的实验研究,中医杂志,1983;24(6):71.
84.杨胜,张永祥,吕晓东等.六味地黄汤活性部位3A的免疫调节作用机理研究.中国中西结合杂志,2001:21(2):119-123.
85.姜廷良,严述常,王素芬等.六味地黄丸防治肿瘤的实验研究[J].中药方剂研究,1983;10(6):71-75.
86.Carystinos GD,Katabi MM,Laird DW,et al.Cyclic-AMP induction of gap junctional intercellular communication increases by stander effect in suicide gene therapy[J].Clin Caner Res,1999;5(5):61-68.
87.雷燕.关于中药血清学的若干思考[J]中国中西医结合志,1999,19(5):263.
88.崔晓兰,贺玉琢.高英杰中药药理研究的新思路一中药血清药理学[J].中国中医药科技1997.4(4):239-250.
89.荣一纯,丁霞,贲长恩等中药血清药理学应用展望[J]。北京中医药大学学报.1999.22(4):42-44.
90.绦瑶,卞国武,矍敏毓等.淫羊藿酵提物对内皮细胞释放NO的影响[J]中国新药与临床葑理2001 12(1):38-40.
91.赵万红,曹永孝,袁泽飞.中药血清药理学的方法探讨(J).中药新药与临床药理,2002:13(2):122-125.
92.蒙一纯,丁霞,郭顺根.中药血清药理学应用研究展望(J)北京中医药大学学报,1999:22(4):42-45.
93.阴桢宏,谭余庆,霍海如等.中药血清药理学研究方法及其应用.中国实验方剂学杂志.1997:3(6):41-45.
94.殷飞,姚树坤,吴新满等.肝症口服液含药血清对TGFA诱导SMMC-7721细胞增殖和ERK蛋白的影响[J].世界华人消化杂志,2001:9(9):1017-1020.
95.周明眉,扬奎,姜远平等.中药血清药理学的方法学研究一含药血清低温保存和血清灭活的影响.中药药理与临床。1999:15(2):44-47.
96.程珠炉,洪浩.中药血清药理学研究方法的几点思考.安徽中医学院学报2001:20(2):53-54.
97.崔玲,晏卫东.中药血清药理研究方法回顾与展望.武警学.2004:15(6):460-461.
98.司徒镇强,吴军正.细胞培养,西安:世界图书出版公司,2003:81-186.
99.刘振英,蔡迎.儿童胫骨棘撕脱性骨折[J].中华骨科杂志,1995,15(7):422-424.
100.陈长勋,金若敏等.用血清药理学实验方法观察附子的强心作用.中国中医药科技,1996;3(3):12-15.
101.吴建宇,李仪奎,符胜光等.补阳还五烫保护自由基损伤内皮细胞的血清药理实验方法的建立[J].中药药理与临床,1999,15(1):45-46
102.Lee SW,Tomasetto C,Sager R.Positive selection of candidate tumor suppressor gene by substractive hybridization.Proc Natl Acad Sci U S A,1991,88(7):2825-2829.
103.Kiang DT,Jin N,Lin HH.Gene expression of gap junction proteins in benign and malignant human breast tissues.Proc Am Assoc Cancer Res,1994,35:276-280.
104.Hirschi KK,Xu C,Tsukamoto T,et al.Gap junction gene Cx26 and Cx43individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential.Cell Growth Diff,1996,7(7):861-870.
105.程蕾,李静,耿美玉.细胞间隙连接通讯与肿瘤.现代生物医学展.2007:7(4):626-627.
106.郑良朴,高冬,林久茂.灌胃刺激对小鼠骨髓造血干细胞的影响.中国比较医学杂志.2008:18(2):52-54.